Starpharma Shares Fall 4 % in 24‑Hour Trading Session
- Trading session ending: 12:48 AM Central Europe, Friday 23 October 2026
- Closing price: AUD 0.47 per share
- Price change: –4 % from the previous close
Market Summary
| Item | Value |
|---|---|
| Current market price | AUD 0.47 |
| Current market capitalization | AUD 239.9 million |
| Total shares outstanding | 499.7 million |
| 24‑hour trading volume | AUD 2.9 million |
| 200‑day simple moving average | AUD 0.63 |
| 52‑week high | AUD 0.88 (30 Sept 2026) |
| 52‑week low | AUD 0.30 (28 Oct 2025) |
| Monthly performance | –40.74 % since end of last month |
The decline of 4 % in the 24‑hour period is the largest single‑day drop since the stock was listed on the Australian Securities Exchange (ASX). The price fell from AUD 0.49 at the open to AUD 0.47 at the close, a move that left the share trading below the 200‑day moving average.
Related Stocks Performance (Last 24 Hours)
| Company | Ticker | Price Change | Current price | Market capitalization |
|---|---|---|---|---|
| St George Mining | SGQ.AX | –3.39 % | AUD 0.06 | AUD 277.4 million |
| Saturn Metals | STN.AX | –1.18 % | AUD 0.42 | AUD 282.3 million |
| Tetratherix | TTX.AX | +2.86 % | AUD 5.52 | AUD 278.6 million |
| Hot Chili | HCH.AX | +2.48 % | AUD 1.40 | AUD 286.1 million |
| Healius | HLS.AX | 0 % | AUD 0.42 | AUD 283.2 million |
Starpharma’s decline is in line with a broader downward trend observed in some commodity‑focused peer companies, while several biotechnology names, such as Tetratherix and Hot Chili, experienced modest gains.
Company Profile
Starpharma Holdings Limited is a biopharmaceutical company focused on the research and commercialization of dendrimer‑based products. Its pipeline targets unmet needs in oncology and infectious diseases. The company’s shares are listed on the ASX All Markets under the ticker SPL.AX. Additional information on the company’s products and research can be found at www.starpharma.com .
